Gelatin-Based Injectable Hydrogels Loaded with Copper Ion Cross-linked Tannic Acid Nanoparticles for Irregular Wound Closure Repair
Source abstract
Abstract
It is often difficult to close and repair irregular wounds such as gums with traditional dressings that have a fixed shape, while injectable hydrogels that can be molded in situ offer tremendous advantages in treating complex, large wounds and can better seal or fill a variety of irregular wounds. While the majority of injectable hydrogels developed in current research have poor mechanical properties and biocompatibility and obstacles to clinical applications, this paper reports an injectable hydrogel that can be molded in situ with appropriate mechanical properties, excellent biocompatibility, and antibacterial activity. Under UV irradiation, a methacrylate-gelatin/poly(vinyl alcohol) loaded with copper ion cross-linked tannic acid nanoparticle (GelMA/PVA-TA/Cu 2+ NPs) precursor solution could rapidly gel within 45 s and adhere stably to the wound tissue by topological adhesion and hydrogen bonding. Through hydrogen bonding and physical entanglement, TA/Cu 2+ NPs are anchored in the GelMA/PVA interpenetrating network to form the GelMA/PVA-TA/Cu 2+ NPs composite hydrogel. This injectable hydrogel, which can quickly achieve photocurable in situ molding, can not only achieve closure and repair of irregular wounds but also has appropriate swelling characteristics, absorbing tissue exudate and blocking bacteria, while providing a good moist environment for wounds and continuously promoting wound healing. Cytotoxicity tests and wound healing experiments have shown that GelMA/PVA-TA/Cu 2+ NPs injectable hydrogels have good biocompatibility and wound closure and repair ability and have promising applications in the treatment of irregularly wounded orifices.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Wound Healing and Treatments · Surgical Sutures and Adhesives · Pressure Ulcer Prevention and Management
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Orthopedics, The Fifth Affiliated Hospital of Guangzhou Medical University, Guangzhou 510700, PR China
Department of Orthopedics, 302 Hospital of China Guizhou Aviation Industry Group, Anshun, Guizhou 561000, PR China
Rehabilitation Medicine Department, Guangdong Second Provincial General Hospital, Guangzhou 510317, PR China
Funding
Guangzhou Medical University · Guangzhou Municipal Science and Technology Project · Traditional Chinese Medicine Bureau of Guangdong Province · Special Clinical Technology Project of Guangzhou
References (54)
Show source-provided references
1. 10.3390/ijms2122874810.3390/ijms21228748 ↗
2. 10.1002/ana.2225510.1002/ana.22255 ↗
3. 10.1021/acsbiomaterials.9b0013010.1021/acsbiomaterials.9b00130 ↗
4. 10.2147/IJN.S17710910.2147/IJN.S177109 ↗
5. 10.1016/j.cej.2022.13936810.1016/j.cej.2022.139368 ↗
6. 10.3390/biomedicines909123510.3390/biomedicines9091235 ↗
7. 10.1016/j.jare.2017.01.00510.1016/j.jare.2017.01.005 ↗
8. 10.1002/ctm2.109410.1002/ctm2.1094 ↗
9. 10.1016/j.mtbio.2023.10058210.1016/j.mtbio.2023.100582 ↗
10. 10.1016/j.cej.2023.14336210.1016/j.cej.2023.143362 ↗
11. 10.1016/j.reactfunctpolym.2021.10505910.1016/j.reactfunctpolym.2021.105059 ↗
12. 10.1016/j.msec.2019.11021510.1016/j.msec.2019.110215 ↗
13. 10.1002/adma.20190800810.1002/adma.201908008 ↗
14. 10.1016/j.compositesb.2022.10966110.1016/j.compositesb.2022.109661 ↗
15. 10.1016/j.jaad.2018.12.03410.1016/j.jaad.2018.12.034 ↗
16. 10.1021/acssuschemeng.8b0146810.1021/acssuschemeng.8b01468 ↗
17. 10.1016/j.carbpol.2021.11828710.1016/j.carbpol.2021.118287 ↗
18. 10.1021/acsapm.9b0098110.1021/acsapm.9b00981 ↗
19. 10.1016/j.carbpol.2022.12024310.1016/j.carbpol.2022.120243 ↗
20. 10.1016/j.carbpol.2021.11878010.1016/j.carbpol.2021.118780 ↗
21. 10.1016/j.actbio.2019.10.00110.1016/j.actbio.2019.10.001 ↗
22. 10.1016/j.ijbiomac.2022.10.19410.1016/j.ijbiomac.2022.10.194 ↗
23. 10.1016/j.carbpol.2022.12019810.1016/j.carbpol.2022.120198 ↗
24. 10.1016/j.ijpharm.2012.08.00110.1016/j.ijpharm.2012.08.001 ↗
25. 10.1039/D2TB01712A10.1039/D2TB01712A ↗
26. 10.1007/s12274-022-5129-110.1007/s12274-022-5129-1 ↗
27. 10.1021/acsabm.3c0020510.1021/acsabm.3c00205 ↗
28. 10.1016/j.jmst.2022.06.00210.1016/j.jmst.2022.06.002 ↗
29. 10.3390/polym1102028510.3390/polym11020285 ↗
30. 10.1016/j.engreg.2021.03.00210.1016/j.engreg.2021.03.002 ↗
31. 10.1016/j.ijbiomac.2022.07.15010.1016/j.ijbiomac.2022.07.150 ↗
32. 10.1039/D2BM01891H10.1039/D2BM01891H ↗
33. 10.1002/smll.20190212310.1002/smll.201902123 ↗
34. 10.1039/C8TB01109E10.1039/C8TB01109E ↗
35. 10.1039/D2TB01938H10.1039/D2TB01938H ↗
36. 10.1002/adhm.20220306310.1002/adhm.202203063 ↗
37. 10.1016/j.carbpol.2021.11771410.1016/j.carbpol.2021.117714 ↗
38. 10.1021/acsami.2c2293210.1021/acsami.2c22932 ↗
39. 10.1016/j.cej.2023.14624510.1016/j.cej.2023.146245 ↗
40. 10.1080/15440478.2020.184870810.1080/15440478.2020.1848708 ↗
41. 10.1016/j.memsci.2023.12136710.1016/j.memsci.2023.121367 ↗
42. 10.1039/D3TB00590A10.1039/D3TB00590A ↗
43. 10.1016/j.compositesb.2022.11001010.1016/j.compositesb.2022.110010 ↗
44. 10.1016/j.cej.2022.13936810.1016/j.cej.2022.139368 ↗
45. 10.1002/mabi.20200039310.1002/mabi.202000393 ↗
46. 10.1016/j.carbpol.2019.11511010.1016/j.carbpol.2019.115110 ↗
47. 10.1016/j.carbpol.2023.12060910.1016/j.carbpol.2023.120609 ↗
48. 10.1016/j.coco.2023.10174310.1016/j.coco.2023.101743 ↗
49. 10.1007/s12598-022-02242-410.1007/s12598-022-02242-4 ↗
50. 10.1016/j.carbpol.2023.12060910.1016/j.carbpol.2023.120609 ↗
51. 10.1021/acsami.7b1081810.1021/acsami.7b10818 ↗
52. 10.1182/blood-2021-15214310.1182/blood-2021-152143 ↗
53. 10.1016/j.cytogfr.2018.04.00410.1016/j.cytogfr.2018.04.004 ↗
54. 10.1136/postgradmedj-2016-13416710.1136/postgradmedj-2016-134167 ↗